Acute massive pulmonary embolism

Also known as: Pulmonary Embolism Acute Massive / Acute massive pulmonary emoblism / Acute massive pulmonary embolism (disorder) / Pulmonary artery embolism / Other pulmonary embolism without acute cor pulmonale / Lung embolism / Embolus pulmonary / Embolism lung / Pulmonary embolism (disorder) / Pulmonary embolism / Pulmonary embolus / Embolism pulmonary

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB00009	Alteplase	A recombinant form of human tissue plasminogen activator used in the emergency treatment of myocardial infarction, ischemic stroke, and pulmonary emboli.
DB00086	Streptokinase	A purified fibrinolytic bacterial protein used to breakdown thrombosis in myocardial infarction, pulmonary embolism, and venous thromboembolism.
DB00013	Urokinase	A low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.

Drug	Drug Name	Target	Type
DB00009	Alteplase	Fibrinogen alpha chain	target
DB00009	Alteplase	Plasminogen	target
DB00009	Alteplase	Plasminogen activator inhibitor 1	target
DB00009	Alteplase	Fibrinogen gamma chain	target
DB00086	Streptokinase	Plasminogen	target
DB00086	Streptokinase	Proteinase-activated receptor 1	target
DB00086	Streptokinase	Cytosolic phospholipase A2	enzyme
DB00013	Urokinase	Urokinase plasminogen activator surface receptor	target
DB00013	Urokinase	Plasminogen	target
DB00013	Urokinase	Plasminogen activator inhibitor 2	target
DB00013	Urokinase	Plasminogen activator inhibitor 1	target
DB00013	Urokinase	Plasma serine protease inhibitor	target
DB00013	Urokinase	Nidogen-1	target
DB00013	Urokinase	Low-density lipoprotein receptor-related protein 2	target
DB00013	Urokinase	Suppressor of tumorigenicity 14 protein	target
DB00013	Urokinase	Macrophage metalloelastase	enzyme

Drug	Drug Name	Phase	Status	Count